Lifevantage Corporation (NASDAQ:LFVN) Shares Will Pay Quarterly Dividend of $0.05

Lifevantage Corporation (NASDAQ:LFVN) declared a quarterly dividend on Monday, November 9th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.05 per share on Tuesday, December 15th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.8%. The ex-dividend date of this dividend is Tuesday, December 1st.

Lifevantage has a dividend payout ratio of 18.5% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Lifevantage to earn $0.53 per share next year, which means the company should continue to be able to cover its $0.20 annual dividend with an expected future payout ratio of 37.7%.

Lifevantage Trading Up 1.3%

LFVN stock opened at $5.29 on Tuesday. The company has a market cap of $66.60 million, a PE ratio of 13.22 and a beta of 0.71. The stock has a 50-day moving average price of $6.04 and a two-hundred day moving average price of $5.88. Lifevantage has a 12-month low of $3.90 and a 12-month high of $11.71.

Lifevantage (NASDAQ:LFVN) last issued its earnings results on Monday, November 9th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.01). The company had revenue of $37.12 million during the quarter, compared to analysts’ expectations of $40.49 million. Lifevantage had a return on equity of 21.56% and a net margin of 2.78%. Equities analysts forecast that Lifevantage will post 0.39 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

LFVN has been the topic of several research reports. Weiss Ratings reissued a “hold (c)” rating on shares of Lifevantage in a research report on Friday, August 21st. Lake Street Capital raised their price target on Lifevantage from $5.00 to $6.00 and gave the company a “hold” rating in a report on Friday, August 28th. Finally, Zacks Research cut shares of Lifevantage from a “hold” rating to a “strong sell” rating in a research note on Friday, October 16th. Two research analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $5.50.

Lifevantage Company Profile

LifeVantage Corporation is a health and wellness company that develops, markets and distributes dietary supplements and personal-care products. Its product portfolio is designed to support areas such as cellular health, antioxidant defenses, energy, nutrition and skin care.

The company’s principal brands have included Protandim, a line of dietary supplements; TrueScience, a skin-care and wellness brand; and Petandim, products formulated for pets. LifeVantage primarily uses a direct-selling business model, distributing its products through independent sales representatives and online channels.

Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets.